Additionally, the protein levels of Mic19 and Mic60 are significantly reduced in MCD-treated mice with NASH and Mic19 overexpression remarkably suppresses MCD-caused live diseases in mice (Fig. 8e, f, and S8g-j). Here, CHCHD3 is linked to metabolic dysfunction-associated steatohepatitis.